Cargando…
Live-Cell Cardiac-Specific High-Throughput Screening Platform for Drug-Like Molecules That Enhance Ca(2+) Transport
We engineered a concatenated fluorescent biosensor and dual-wavelength fluorescence lifetime (FLT) detection, to perform high-throughput screening (HTS) in living cells for discovery of potential heart-failure drugs. Heart failure is correlated with insufficient activity of the sarcoplasmic reticulu...
Autores principales: | Schaaf, Tory M., Kleinboehl, Evan, Yuen, Samantha L., Roelike, Lauren N., Svensson, Bengt, Thompson, Andrew R., Cornea, Razvan L., Thomas, David D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291019/ https://www.ncbi.nlm.nih.gov/pubmed/32397211 http://dx.doi.org/10.3390/cells9051170 |
Ejemplares similares
-
FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
por: Roopnarine, Osha, et al.
Publicado: (2023) -
Fluorescence lifetime FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
por: Roopnarine, Osha, et al.
Publicado: (2023) -
Red-Shifted FRET Biosensors for High-Throughput Fluorescence Lifetime Screening
por: Schaaf, Tory M., et al.
Publicado: (2018) -
The transmembrane peptide DWORF activates SERCA2a via dual mechanisms
por: Li, Ang, et al.
Publicado: (2021) -
Targeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cells
por: Stroik, Daniel R., et al.
Publicado: (2018)